Max Healthcare Institute Limited
NSE: MAXHEALTH BSE: MAXHEALTH
Prev Close
973.8
Open Price
961.5
Volume
1,262,069
Today Low / High
940.05 / 997.9
52 WK Low / High
719.45 / 1227.95
Range
946 - 1,045
Prev Close
973.2
Open Price
972.95
Volume
9,736
Today Low / High
940.35 / 994.8
52 WK Low / High
714.7 / 1227.5
Range
941 - 1,040
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 995.3 (target range: 946 - 1,045), reflecting a change of 21.5 (2.20785%). On the BSE, it is listed at 990 (target range: 941 - 1,040), showing a change of 16.8 (1.72626%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Max Healthcare Institute Limited Graph
Max Healthcare Institute Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking Target Price for Max Healthcare Institute Limited T1, T2, T3, for both Bullish or Bearish. For Bullish T1, T2, T3 and for Bearish T1, T2, T3. The stock current price is 995, with potential price targets ranging from T1, T2, T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 990.00 | 999.90 | 899.91 - 1,099.89 |
1,009.80 | 807.84 - 1,211.76 | ||
1,019.70 | 713.79 - 1,325.61 | ||
Bearish Scenario | 990.00 | 980.10 | 882.09 - 1,078.11 |
970.20 | 776.16 - 1,164.24 | ||
960.30 | 672.21 - 1,248.39 |
Overview of Max Healthcare Institute Limited
ISIN
INE027H01010
Industry
Medical - Care Facilities
Vol.Avg
2,315,699
Market Cap
969,517,216,600
Last Dividend
1.5
Official Website
IPO Date
2020-08-21
DCF Diff
-89.66
DCF
1,063
Financial Ratios Every Investor Needs
Stock Dividend of MAXHEALTH
Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|---|
2024-08-23 | August 23, 24 | 1.5 | 1.5 | 2024-08-23 | 2024-10-20 | |
2023-09-08 | September 08, 23 | 1 | 1 | 2023-09-08 | 2023-10-27 |
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 5,406.02 Cr | 2,052.92 Cr | 3,353.10 Cr | 0.6203 | 0.51 Cr | 1,116.89 Cr | 2,235.70 Cr | 1,057.64 Cr | 10.89 | 1,670.19 Cr | 0.1956 |
2023-03-31 | 4,562.60 Cr | 922.01 Cr | 3,640.59 Cr | 0.7979 | 0.36 Cr | 986.31 Cr | 1,024.02 Cr | 1,103.51 Cr | 11.38 | 1,379.77 Cr | 0.2419 |
2022-03-31 | 3,883.19 Cr | 922.90 Cr | 2,960.29 Cr | 0.7623 | -159.84 Cr | 908.19 Cr | 757.96 Cr | 605.05 Cr | 6.25 | 1,060.89 Cr | 0.1558 |
2021-03-31 | 2,482.41 Cr | 594.41 Cr | 1,888.00 Cr | 0.7606 | 0.00 Cr | 583.25 Cr | 243.05 Cr | -137.55 Cr | -1.59 | 284.90 Cr | -0.0554 |
2020-03-31 | 1,861.71 Cr | 391.78 Cr | 1,469.93 Cr | 0.7896 | 0.00 Cr | 492.45 Cr | 48.22 Cr | 95.34 Cr | 1.77 | 141.66 Cr | 0.0512 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 979.84 Cr | 11,999.94 Cr | 3,591.80 Cr | 8,408.1400 Cr | 1,507.89 Cr | 528.05 Cr | 79.84 Cr | 3,691.08 Cr | 49.15 Cr | 16.89 Cr | 2.12 Cr | 1,248.7100 Cr |
2023-03-31 | 42.75 Cr | 10,101.85 Cr | 2,692.26 Cr | 7,409.5900 Cr | 688.96 Cr | 646.21 Cr | 76.23 Cr | 2,225.63 Cr | 332.93 Cr | 11.73 Cr | 0.51 Cr | 1,045.5700 Cr |
2022-03-31 | 309.14 Cr | 9,189.13 Cr | 2,906.66 Cr | 6,282.4700 Cr | 1,132.67 Cr | 823.53 Cr | 61.36 Cr | 2,058.32 Cr | 118.84 Cr | 10.82 Cr | 2.02 Cr | 757.2700 Cr |
2021-03-31 | 626.59 Cr | 8,544.44 Cr | 2,905.76 Cr | 5,638.6800 Cr | 1,325.26 Cr | 698.67 Cr | 53.80 Cr | 1,774.91 Cr | 188.10 Cr | 11.41 Cr | 1.04 Cr | 776.9300 Cr |
2020-03-31 | 274.79 Cr | 3,824.38 Cr | 2,836.97 Cr | 987.4100 Cr | 1,514.91 Cr | 1,240.12 Cr | 43.37 Cr | 1,148.29 Cr | 629.21 Cr | 1.63 Cr | 2.46 Cr | 1,474.4200 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 1,121.8000 Cr | -1,285.4500 Cr | -263.7400 Cr | 343.0200 Cr | -394.4900 Cr | 979.8400 Cr | -778.7800 Cr | 1,057.6400 Cr | 78.1300 Cr | -97.0100 Cr | 5.9000 Cr |
2023-03-31 | 1,209.1800 Cr | -1,187.0100 Cr | -288.5600 Cr | 873.5700 Cr | -266.3900 Cr | 42.7500 Cr | -335.6100 Cr | 1,063.7200 Cr | -161.7600 Cr | 0.0000 Cr | -14.8700 Cr |
2022-03-31 | 748.4900 Cr | -771.7700 Cr | -294.1700 Cr | 187.1800 Cr | -317.4500 Cr | 309.1400 Cr | -561.3100 Cr | 738.9000 Cr | -227.1600 Cr | 0.0000 Cr | -7.5600 Cr |
2021-03-31 | 117.8600 Cr | -73.0000 Cr | 191.3300 Cr | -0.5600 Cr | 515.5800 Cr | 626.5900 Cr | -118.4200 Cr | -68.6500 Cr | -791.1200 Cr | 0.0000 Cr | 17.2500 Cr |
2020-03-31 | 249.8200 Cr | -126.6800 Cr | 144.0500 Cr | 161.0800 Cr | 267.1900 Cr | 274.7900 Cr | -88.7400 Cr | 89.0800 Cr | 580.5300 Cr | 0.0000 Cr | -17.3100 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2024-12-31 | 1,868.31 Cr | 391.82 Cr | 1,476.49 Cr | 0.7903 | 0.00 Cr | 238.80 Cr | 2.46 | 458.80 Cr | 0.1278 |
2024-09-30 | 1,707.46 Cr | 1,071.71 Cr | 635.75 Cr | 0.3723 | 366.39 Cr | 281.81 Cr | 2.90 | 491.38 Cr | 0.1650 |
2024-06-30 | 1,542.95 Cr | 1,001.18 Cr | 541.77 Cr | 0.3511 | 310.51 Cr | 236.27 Cr | 2.43 | 422.09 Cr | 0.1531 |
2024-03-31 | 1,422.90 Cr | 900.31 Cr | 522.59 Cr | 0.3673 | 311.21 Cr | 251.54 Cr | 2.59 | 426.78 Cr | 0.1768 |
2023-12-31 | 1,334.97 Cr | 267.28 Cr | 1,067.69 Cr | 0.7998 | 370.92 Cr | 289.34 Cr | 2.98 | 431.88 Cr | 0.2167 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2024-09-30 | 963.96 Cr | 322.35 Cr | 1,286.31 Cr | 528.69 Cr | 93.42 Cr | 1,980.76 Cr | 4,507.20 Cr | 13,126.87 Cr | 4,327.81 Cr |
2024-06-30 | -1,099.27 Cr | 2,198.54 Cr | 1,099.27 Cr | 0.00 Cr | 0.00 Cr | 1,099.27 Cr | 0.00 Cr | 0.00 Cr | -8,408.14 Cr |
2024-03-31 | 1,099.27 Cr | 160.77 Cr | 1,099.27 Cr | 496.65 Cr | 79.84 Cr | 1,706.18 Cr | 3,691.08 Cr | 11,999.94 Cr | 3,591.80 Cr |
2023-12-31 | -1,791.88 Cr | 3,583.76 Cr | 1,791.88 Cr | 0.00 Cr | 0.00 Cr | 1,791.88 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-09-30 | 1,581.58 Cr | 244.03 Cr | 1,825.61 Cr | 430.37 Cr | 71.56 Cr | 2,365.70 Cr | 2,322.31 Cr | 10,656.33 Cr | 2,810.31 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2024-06-30 | 236.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-03-31 | 251.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-12-31 | 289.34 Cr | 121.92 Cr | 0.00 Cr | 0.00 Cr | 121.92 Cr | 1,913.80 Cr | 1,791.88 Cr | 0.00 Cr | 121.92 Cr |
2023-09-30 | 276.68 Cr | 115.76 Cr | 0.00 Cr | 0.00 Cr | 115.76 Cr | 1,791.88 Cr | 1,676.12 Cr | 0.00 Cr | 115.76 Cr |
2023-06-30 | 240.08 Cr | 111.64 Cr | 0.00 Cr | 0.00 Cr | 111.64 Cr | 247.78 Cr | 136.14 Cr | 0.00 Cr | 111.64 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
No split history data available. |
Similar Stocks: Medical - Care Facilities
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
Max Healthcare Institute Limited | MAXHEALTH | ₹996.00 | ₹968,253,432,000.00 | ₹1,258,024.00 |
Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹6,200.80 | ₹891,582,028,000.00 | ₹265,521.00 |
Fortis Healthcare Limited | FORTIS | ₹653.05 | ₹493,025,321,900.00 | ₹997,909.00 |
Narayana Hrudayalaya Limited | NH | ₹1,666.05 | ₹340,475,644,050.00 | ₹6,941,266.00 |
Global Health Limited | MEDANTA | ₹1,214.20 | ₹326,118,784,654.00 | ₹153,345.00 |
Krishna Institute of Medical Sciences Limited | KIMS | ₹510.30 | ₹204,190,931,700.00 | ₹233,650.00 |
Aster DM Healthcare Limited | ASTERDM | ₹399.10 | ₹199,355,638,300.00 | ₹160,408.00 |
Rainbow Children's Medicare Limited | RAINBOW | ₹1,283.65 | ₹130,356,806,330.00 | ₹51,478.00 |
HealthCare Global Enterprises Limited | HCG | ₹508.75 | ₹70,921,276,250.00 | ₹630,381.00 |
Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Artemis Medicare Services Limited | ARTEMISMED | ₹222.35 | ₹32,228,323,748.00 | ₹55,218.00 |
Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹332.90 | ₹30,517,941,700.00 | ₹182,378.00 |
Shalby Limited | SHALBY | ₹189.48 | ₹20,465,734,800.00 | ₹33,828.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1970
Gender: Not Specified
Year Born: 1972
Gender: male
Year Born: 1973
Gender: Not Specified
Year Born: 1958
Gender: male
Year Born: 1978
Gender: male
Year Born: 1965
Gender: male
Year Born: 1973
FAQs about Max Healthcare Institute Limited
The CEO is Mr. Abhay Soi.
The current price is ₹997.30.
The range is ₹719.45-1227.95.
The market capitalization is ₹96,951.72 crores.
The dividend yield is 0.15%.
The P/E ratio is 96.00.
The company operates in the Healthcare sector.
Overview of Max Healthcare Institute Limited (ISIN: INE027H01010) is a leading Medical - Care Facilities in India. With a market capitalization of ₹96,951.72 crores and an average daily volume of 2,315,699 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹1.5.